ANL 30.68 Increased By ▲ 1.83 (6.34%)
ASC 14.94 Decreased By ▼ -0.21 (-1.39%)
ASL 23.90 Decreased By ▼ -0.25 (-1.04%)
AVN 92.00 Decreased By ▼ -5.95 (-6.07%)
BOP 9.14 Decreased By ▼ -0.16 (-1.72%)
BYCO 10.25 Decreased By ▼ -0.10 (-0.97%)
DGKC 135.60 Increased By ▲ 0.10 (0.07%)
EPCL 50.00 Increased By ▲ 0.02 (0.04%)
FCCL 24.62 Decreased By ▼ -0.54 (-2.15%)
FFBL 24.25 Decreased By ▼ -0.97 (-3.85%)
FFL 15.60 Decreased By ▼ -0.44 (-2.74%)
HASCOL 10.74 Decreased By ▼ -0.33 (-2.98%)
HUBC 85.20 Increased By ▲ 0.20 (0.24%)
HUMNL 7.35 Decreased By ▼ -0.35 (-4.55%)
JSCL 24.85 Decreased By ▼ -0.90 (-3.5%)
KAPCO 37.85 Increased By ▲ 0.40 (1.07%)
KEL 4.15 Decreased By ▼ -0.02 (-0.48%)
LOTCHEM 14.78 Decreased By ▼ -0.35 (-2.31%)
MLCF 46.60 Decreased By ▼ -0.58 (-1.23%)
PAEL 38.25 Decreased By ▼ -1.15 (-2.92%)
PIBTL 11.80 Decreased By ▼ -0.24 (-1.99%)
POWER 10.50 Decreased By ▼ -0.15 (-1.41%)
PPL 90.55 Decreased By ▼ -0.45 (-0.49%)
PRL 26.10 Decreased By ▼ -0.59 (-2.21%)
PTC 8.95 Decreased By ▼ -0.10 (-1.1%)
SILK 1.40 Decreased By ▼ -0.05 (-3.45%)
SNGP 38.10 Decreased By ▼ -0.65 (-1.68%)
TRG 141.10 Decreased By ▼ -4.60 (-3.16%)
UNITY 31.50 Decreased By ▼ -1.40 (-4.26%)
WTL 1.57 Decreased By ▼ -0.04 (-2.48%)
BR100 4,936 Decreased By ▼ -22.94 (-0.46%)
BR30 25,403 Decreased By ▼ -330.65 (-1.28%)
KSE100 45,865 Decreased By ▼ -100.6 (-0.22%)
KSE30 19,173 Decreased By ▼ -26.07 (-0.14%)
World

Hungary buys Russia's Sputnik V vaccine, first in EU, minister says

  • Under the terms of our agreement, we are buying an amount sufficient to inoculate 1 million people.
  • This represents 2 million doses in three tranches. An amount to inoculate 300,000 people in the first month.
22 Jan 2021

BUDAPEST: Hungary has signed a deal to buy 2 million doses of Russia's Sputnik V COVID-19 vaccine, the first European Union country to do so, Foreign Minister Peter Szijjarto told a briefing during talks in Moscow on Friday.

With its order for Russia's COVID-19 vaccine, Hungary is the first EU member to break ranks and unilaterally approve the shot as frustrations build in Europe over delays in supplies of Western vaccines that are hampering an economic recovery.

"Under the terms of our agreement, we are buying an amount sufficient to inoculate 1 million people," Szijjarto said during talks with his Russian counterpart, Sergei Lavrov.

"This represents 2 million doses in three tranches. An amount to inoculate 300,000 people in the first month, for half a million people in the second month and 200,000 people in the third."

Szijjarto did not say when the first shipment of the Russian shot would arrive in Hungary and it was unclear how much Budapest would pay for the 2 million vaccines in total.

The agreement comes only days after Hungary's drug regulator gave approval for use of Britain's AstraZeneca and Russia's Sputnik V vaccines against the coronavirus, as Budapest strives to lift coronavirus lockdown measures to boost its economy.

The EU's medicines regulator has yet to approve the Russian or AstraZeneca vaccine. Szijjarto said the Russian vaccines could allow Hungary to lift lockdown restrictions sooner.

Earlier on Friday, Prime Minister Viktor Orban said Hungary cannot lift restrictions until it can carry out a mass inoculation. He said the best approach was to authorise the use of several vaccines as competition would force manufacturers to speed up shipments.

"We don't need explanations, we need vaccines," Orban told state radio.

Right-wing conservative Orban has pursued what he has called good pragmatic relations with Russia ever since he came to power in 2010. Hungary relies mostly on natural gas imported from Russia, and Rosatom is building a nuclear power plant in Hungary.

Szijjarto has said he would also discuss gas shipments from Russia during his talks in Moscow on Friday. Hungary has said before that it was ready to start talks with Russia's Gazprom about a new long-term gas-supply deal.

EUROPEAN APPROVAL STILL PENDING

The European Medicines Agency (EMA) is expected to decide on the vaccine developed by AstraZeneca and Oxford University on Jan. 29.

Russia on Wednesday filed for registration of the Sputnik vaccine in the EU before an EMA review next month.

Scientists have raised concern about the speed at which Moscow has launched its vaccine, giving the regulatory go-ahead for the shot at home and beginning mass vaccinations before full trials to test its safety and efficacy had been completed.

Moscow has said Sputnik V is 92% effective at protecting people from COVID-19 based on interim results but has not yet released the full dataset for the trials.